If you’re warning about a specific tablet, please tell me its name (or send a photo of the package). The risk of blood clots or heart attack depends heavily on the exact medicine.
For example, some medicines—including certain JAK inhibitors such as tofacitinib, baricitinib, and upadacitinib—carry regulatory warnings about increased risks of serious cardiovascular events and blood clots. U.S. Food and Drug Administration+1
If someone taking the tablets currently has chest pain/pressure, shortness of breath, sudden weakness or numbness, difficulty speaking, or other symptoms suggesting a heart attack, stroke, or blood clot, seek emergency medical care immediately. U.S. Food and Drug Administration
Don’t stop a prescribed medicine suddenly without medical advice, because for some medicines abrupt discontinuation can itself increase clot or heart-attack risk. U.S. Food and Drug Administration
Send me the tablet name and strength (for example, “10 mg”), and I can check its specific warnings.
